Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-05-03 | Gregg H. Alton, Ph.D. Former Interim Chief Executive Officer and Chief Patient Officer, Gilead Sciences Age 55 Director Since 2020 Committees: Audit Compensation: $564,513 total compensation in 2020. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22